Ezetimibe/pitavastatin calcium (AJU Pharm)

依折麦布/匹伐他汀钙 (AJU Pharm)

Report date: 2025/07/08 20:00:08

Base Information

Drug NameEzetimibe/pitavastatin calcium (AJU Pharm)
Drug Alias NameAJU-C711
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHMG-CoA reductase inhibitorsCholesterol absorption inhibitorsNiemann-Pick C1-like protein 1 inhibitors
TargetsHMG-CoA reductaseNiemann-Pick C1-like protein 1
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAju Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAju Pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsHypercholesterolemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A